Ever Source Wealth Advisors, LLC Pyxis Oncology, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 484 shares of PYXS stock, worth $571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
484Holding current value
$571% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PYXS
# of Institutions
89Shares Held
23.1MCall Options Held
138KPut Options Held
30.9K-
Laurion Capital Management LP New York, NY3.63MShares$4.28 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$3.29 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.49MShares$2.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$2.88 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$1.31 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $41.4M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...